Skip to main content

What is Pickaxe Mountain, Iran’s secretive facility Trump says the US will attack ‘pretty soon’?

Trump: US will be 'hitting' Pickaxe Mountain 'pretty soon'

(CNN) — President Donald Trump continues to claim that the US will attack Iran’s Pickaxe Mountain – turning attention to the suspected underground nuclear site where Israel believes Tehran has stored part of its enriched uranium stockpile and advanced enrichment centrifuges.

“We’ll be hitting that area very probably pretty soon. And there’s not a thing they can do about it,” Trump said on Tuesday.

In response, Tehran warned that that any US attack on Iranian nuclear facilities would be treated as an expansion of the war in the region, state media reported early Wednesday.

Here’s what we know about Pickaxe Mountain.

What is it?

Pickaxe Mountain is a heavily fortified facility located deep underground in the center of the country, about a mile south of the Natanz uranium-enrichment facility previously bombed by the US and Israel – making it a difficult target for the US and Israel, and for any potential ground operation.

The facility is buried at least 100 meters (328 feet) under a large mountain called Kuh-e Kolang Gaz La, with Kolang translating to Pickaxe, according to the Institute for Science and International Security (ISIS).

Construction on the facility began in 2020; at the time, Iran declared the facility to the UN’s International Atomic Energy Agency as a future facility to assemble the centrifuges that make nuclear fuel.

The facility is largely shrouded in mystery; there are no publicly available schematics, and experts largely glean their insights by analyzing satellite imagery. Through these images, ISIS said in a recent report, we know the facility has several tunnel complexes, a large security perimeter, and entrances that have been hardened by concrete for protection from potential airstrikes.

The facility is believed to not yet be operational, with construction ongoing. Those efforts may have intensified in the past year, with construction increasing after Israel and the US targeted Iran’s other nuclear facilities in June 2025. Among the facilities struck was the Natanz uranium enrichment complex, just a few miles from Pickaxe Mountain.

There are several possible reasons for this increased activity at the Pickaxe site, said the Center for Strategic & International Studies. Iran could be building centrifuges, as it told the UN it would; it could be expanding its mission, bringing over operations from the other destroyed facilities; or it could be creating a secret facility to enrich uranium, a key component to make nuclear weapons.

Is there enriched uranium there?

Israeli intelligence believes Iran moved part of its enriched uranium stockpile and advanced enrichment centrifuges to Pickaxe Mountain after last June’s attacks, an Israeli source familiar with the matter told CNN.

During that 12-day war, Israel struck three key Iranian nuclear facilities – Natanz, Isfahan and Fordow – and killed a number of top scientists involved in nuclear research and development. The US joined the fight near the end of the war, striking the same three facilities with much more powerful bombs, attacks in which Trump claimed Iran’s nuclear capabilities had been “obliterated.” But neither the US, nor Israel struck Pickaxe Mountain.

US and UN intelligence later suggested that parts of Iran’s nuclear program remain intact, albeit damaged. And it since become a shared goal of both the US and Israel to either make Iran dispose of its nearly 1,000-pound stockpile of highly enriched uranium, or to take it from them.

CNN previously reported that Iran had dramatically escalated efforts to seal off its cache of near bomb-grade uranium, deliberately collapsing tunnels and booby-trapping entrances with explosive mines.

When asked on Tuesday whether Iran had moved its advanced centrifuges to Pickaxe Mountain, Trump seemingly downplayed the Israeli reports, saying: “We don’t have it on record.”

Earlier in July, a senior security source in Tehran told CNN that the claims of nuclear activities taking place at Pickaxe Mountain were false.

Iran maintains that its nuclear program is solely for peaceful energy purposes, and plans to build additional nuclear power plants to meet domestic energy needs and free up more oil for export.

Could it be attacked by the US and Israel?

Analysts have mixed opinions.

One nonproliferation expert, Andrea Stricker, told CNN that Trump should act to disable Pickaxe Mountain to prevent Iran from “reconstituting an enrichment or nuclear weapons option, and having access to thousands of centrifuges that represent the remnants of its nuclear program.”

While a ground operation would be complex, the ISIS report pointed out several possible avenues for attack.

The secretive facility would need ventilation, heating, cooling, deliveries, power supply, and personnel – which all present “vulnerabilities that the U.S. and Israel would seem to be able to exploit,” it said.

Strikes, though, may not have the desired impact because the core part of the facility is likely deeply buried.

James Acton, who co-leads the Carnegie Endowment’s nuclear policy work, posted on X that he doubts the US can do much more than collapse access tunnels at the Pickaxe Mountain facility. “That isn’t a game changer,” Acton said.

The-CNN-Wire
™ & © 2026 Cable News Network, Inc., a Warner Bros. Discovery Company. All rights reserved.

Transcript: Former FDA commissioner Dr. Scott Gottlieb on ‘Face the Nation with Margaret Brennan,’ July 26, 2026

▶ Watch Video: Former FDA head praises response to cyclospora outbreak, but says it's not "under control yet" The following is the transcript of an interview with U.S. Ambassador to the United Nations Mike Waltz that aired on "Face the Nation with Margaret Brennan" on July 26, 2026.MARGARET BRENNAN: We turn now to former FDA Commissioner Dr. Scott Gottlieb. He sits on the boards of Pfizer and UnitedHealth. Dr. Gottlieb, it's good to have you back. We've got cyclospora outbreaks in nine states. It is now one of the nation's largest foodborne illness outbreaks. HHS Secretary Kennedy says it's under control. Do you think it is? DR. SCOTT GOTTLIEB: I don't think it's under control yet, per se. I think that they've done a good job, FDA has, isolating this to central Mexico and some specific farms as well. It appears that a lot of these cases are emanating from farms in central Mexico, and there was probably some kind of event there. Remember, this particular parasite-the only known reservoir for it is human fecal matter, so probably sewage got onto those growing fields in central Mexico and contaminated those crops. Nobody's sure how yet. And so by isolating it to that region, a lot of restaurants, a lot of wholesalers, retailers have been able to cut off supplies from central Mexico, and I think that mitigates the risk. I don't think this is fully under control yet because we don't know for sure that that's the only growing region where this is coming from. But it does seem to be the case at this point. Some of the cases that are being reported right now probably are cases happening from other parts of the- the world and other parts of the country that are normal background cases that you see. There's probably increased reporting, but clearly the bulk of these cases appear to be coming from that central Mexican region. It's worth noting that Mexican authorities, public health authorities, deny that they're responsible for this.MARGARET BRENNAN: Well, I saw you recommended people buy heads of lettuce, not pre-chopped bags, buy locally, not from the grocery store. Why aren't we hearing more from the current FDA commissioner on that kind of advice?DR. SCOTT GOTTLIEB: Yeah, look, I think that there is some challenges with communications from the FDA. I think FDA has done a good job isolating this, and they were fast to do this. This is a hard pathogen to detect. There's no really good test for it, so you can't test for it in food. But there hasn't been as much communication from the agency as you might expect. There are things that consumers can do. You can buy a whole head of lettuce, like you said, and chop it up rather than buying bag lettuce. There's higher risk with bag lettuce. You can source locally. There haven't been known outbreaks from locally sourced produce. Prior to 2016, 2017, we never saw this particular species in U.S. sourced produce. It started to appear in California produce, but certainly in lower levels than what you see in Mexico and South America. There is a weather component here.MARGARET BRENNAN: There is, though, as you know, a public- public confidence crisis here when it comes to our health agencies. Our polling showed 47% of Americans do not have much confidence in the FDA to deal with the outbreak. That must hit hard as the former FDA commissioner. But it's also in part in the public space. They're looking not just at the personnel cuts, but like the Wall Street Journal is reporting that Taylor Farms, one of the companies that is- has been identified as- as selling some of the lettuce, at least that is in question. They contacted the White House to request a delay in announcing a recall, and the White House had the FDA join that call. That is not standard operating procedure, is it?DR. SCOTT GOTTLIEB: No, it's not, and it wasn't standard operating procedure when I was at FDA. I dealt with outbreaks in romaine lettuce and spinach as well, E. coli in spinach and romaine lettuce. I never heard from the White House on those things, other than to have discussions to inform them of what we were doing, so that they were properly briefed and could respond to questions that they were getting. So it's unusual. I don't think it really led to a significant delay in the ability of FDA to communicate in this case, based on that reporting, probably days, certainly not weeks. I think the breakdown here really was with CDC in identifying that initial cluster. By and large, we were dependent upon public health officials in Michigan to isolate that cluster. CDC really didn't seem to be as involved as the agency normally would be. Michigan public health officials led that response. Once they- once they isolated the cluster, however, the traceback to the farm and to the particular food source happened relatively fast. We had an outbreak of E. coli in romaine lettuce back in 2018. It took us many weeks to isolate that to a specific growing region. They were able to do that in a matter of, maybe days here, certainly weeks. So I think FDA worked pretty quickly to do it. MARGARET BRENNAN: I want to ask you about the CDC announcement that there are now more measles infections in 2026 than in the past 35 years. The American Academy of Pediatrics warns it's America's children that are going to pay the price for this. Ninety-three percent of this year's cases are among the unvaccinated, or the vaccination status is unknown. Should we, at any point, expect the Trump administration to lead a national campaign to get your kid vaccinated against measles, or did that die with MAHA? DR. SCOTT GOTTLIEB: Yeah, look, I think we need to accept that measles elimination is no longer the policy of this administration or certainly Secretary Kennedy, and I wouldn't expect any kind of concerted effort so long as he is in that position. This is his stated policy to, in some cases, discourage vaccination, but certainly not encourage it. And the children who aren't getting vaccinated right now are babies. Once they age into settings where they can contract that disease – kindergarten, preschool, daycare – you're going to see cases continue to rise in this country. It's not going to go down; it's going to continue to go up. Look at flu, for example. We had a record number of pediatric flu deaths last year, 298 pediatric flu deaths. We have almost 200 this year, and the secretary has said children don't need to get vaccinated for flu. So this is across the board; it's not just measles. These infections are very serious. There's a lot of long-term sequelae, even if you survive the infection.MARGARET BRENNAN: Let me quickly ask you. Supplement makers don't have to do what pharmaceutical companies do in terms of proving through clinical trials that products are safe. There's this push for this advisory board at the FDA to make, I guess, six peptides be added to a list of substances pharmacies can compound and produce. Is that wider access a good thing or a bad thing?DR. SCOTT GOTTLIEB: Well, I think it's a bad thing from the standpoint that there's not any proven benefits from these compounds that are in question. These are compounds being formulated by pharmacies. They're compounded products. They're peptides that people inject. There's risks associated with that, and there aren't any proven benefits. The most popular of these is the substance called PBC-157,* which people have ascribed a whole range of health benefits to. The only clinical study that the FDA was able to review was a 30-patient clinical study in a setting of ulcerative colitis, where they found no benefit. So there isn't clinical data associated with these, so I think there's risk with no- no demonstrated benefit that people are going to derive.MARGARET BRENNAN: Dr. Gottlieb, I've got to leave it there. Always good to talk to you. We'll be right back.EDITOR'S NOTE: This was in reference to the peptide BPC-157, not PBC-157.
Read Next Story